Shaping the Future of Cannabis.

About

Background Vision

ECH is a London based venture builder focused on building the medical cannabis market in Europe - we build, invest or partner with companies in this space.

We have a fast growing portfolio of private companies that focus on ancillary products to the medical cannabis sector, across three key pillars; Platforms, Brands and Access. These are the areas that we believe will shape the future of the industry across Europe.

Our operational expertise in starting and growing business in the medical cannabis space is second to none. And, our global network and knowledge gives our portfolio the very best chance to perform at the absolute best of their ability.

As the medical cannabis industry opens and talent and new businesses pour in, ECH is ideally placed to work with the very best and achieve huge success across the eco system.

ECH is an unrivalled group of companies at the forefront of the European market – we provide venture capital, exceptional talent and operational excellence. We build the platforms and brands that will shape the industry for years to come.

We have a fast growing portfolio of private companies that focus on ancillary products to the medical cannabis sector, across three key pillars; Platforms, Brands and Access. These are the areas that we believe will shape the future of the industry across Europe.

We are all known to influence and drive sustained scalable and profitable change. And, our global network and knowledge gives our portfolio the very best chance to perform at the absolute best of their ability.

As the medical cannabis industry opens and talent and new businesses pour in, ECH is ideally placed to work with the very best and achieve huge success across the eco system.

Driving leadership, innovation and growth in Europe’s cannabis industry, we are an unrivalled group of companies at the forefront of the market. Our brands are well known and instrumental in driving sustained, scalable and profitable change.

Shaping the future of cannabis.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Hoc est non dividere, sed frangere. Quae sequuntur igitur? Tria genera bonorum; Quae ista amicitia est? Duo Reges: constructio interrete. Sed haec in pueris; Sed fortuna fortis; Negat esse eam, inquit, propter se expetendam.

Est enim effectrix multarum et magnarum voluptatum. Praeclarae mortes sunt imperatoriae; Omnia contraria, quos etiam insanos esse vultis. Cur id non ita fit?

Ecce aliud simile dissimile. Videmus igitur ut conquiescere ne infantes quidem possint. Verum hoc idem saepe faciamus. Oratio me istius philosophi non offendit; Tum ille: Ain tandem? Non potes, nisi retexueris illa.

Et non ex maxima parte de tota iudicabis? Easdemne res? Itaque ab his ordiamur. An hoc usque quaque, aliter in vita? Quid est igitur, inquit, quod requiras?

Vision

ECH is on a mission to shape the future of cannabis.

We are building the infrastructure that will make cannabis more readily acceptable and accessible. 

We have identified gaps in the emerging market and invest in developing assets with significant upside potential over the short to medium term.

We provide venture capital, exceptional talent and operational excellence to a fast-growing portfolio of companies across three key pillars: Platforms, Brands, and Access.

These key areas will shape the future of the industry for years to come.

Read

Read

Read

Read

Read

Prohibition Partners

Overview

Prohibition Partners was founded in 2017 with a mission to open up the international cannabis industry through reliable data and intelligence.

Within two years, they have become the world’s leading provider of market insights and strategic consultancy for this emerging frontier. They firmly believe that data, insights and education will unlock the societal and commercial potential of cannabis.

Their research and content teams routinely share the latest legislative developments and key trends in the industry - information that is regularly cited by political leaders, investment banks and Fortune 500 companies.

Prohibition Partners consultancy team works with investors, operators and regulators to identify and execute opportunities across multiple jurisdictions. They advise private clients on licensing, regulatory and business opportunities.


Cannabis Europa

Overview

Cannabis Europa is the go to conference for business leaders in medical cannabis. Known as Europe’s premier medical cannabis conference to share knowledge and shape the future of cannabis in Europe, it is now in it’s 2nd year and will host an A-list speaker circuit across events in London and Paris in 2019.

Cannabis requires a multidisciplinary approach and Cannabis Europa sits at that intersection.


The Academy of Medical Cannabis

Overview

The definitive name in medical cannabis education for the global healthcare sector. The Academy of Medical Cannabis is a comprehensive set of online learning modules created by one of the world’s leading experts, Professor Mike Barnes.


Amkeu

Overview

Innovators in CBD brands and products, as well as operating Europe’s premier cannabis CPG distribution hub. Amkeu is operated by a team of F&B specialists from around the world, with experience from some of the most well-respected brands.


The Medical Cannabis Clinic

Overview

The Medical Cannabis Clinics is a chain of private UK clinics specialising in innovative cannabis-based therapy and prescription cannabinoids.

They provide effective care for all patients who currently suffer from conditions for which existing treatments are not effective.

The team is the most experienced and respected group of medical practitioners working with cannabis in the UK including leading experts across Pain, Neurology and Psychiatry.

The first clinic is opening on Harley Street, London in April followed by Manchester and Birmingham locations in May. We will quickly become the UK’s largest and most progressive network of private cannabis clinics.


Leadership

Board of Directors

Management Team

Medical Advisory Board

News

ECH creates historic milestone as first cannabi...

15th February 2019

European Cannabis Holdings (ECH), Grow Biotech, and IPS Specials have created a historic milestone by importing...

Read Article

The Academy of Medical Cannabis launches its on...

8th February 2019

The Academy of Medical Cannabis (www.taomc.org), Europe’s first medical cannabis online education platform, has today launched...

Read Article

Prohibition Partners: UK Medicinal Cannabis Use...

6th February 2019

Despite UK doctors being legally able to prescribe medical cannabis since November 1st 2018, patients still struggle to...

Read Article

Contact

From:

Telephone:

Subject:

Message Body

This form collects your contact information so that we can correspond with you.Please review our privacy policy for more information about how we protect and manage your data.